Sustained virological response: A milestone in the treatment of chronic hepatitis C

Table 1 Baseline characteristics of 150 chronically infected hepatitis C virus patients with sustained virological response

Patients	150
Gender
Male	100
Female	50
Patients with histological assessment[20]	103
Mild hepatitis (G0-G4)	52
Moderate hepatitis (G5-G9)	44
Severe hepatitis (G10-G18)	5
Staging S0-S1	44
Staging S2	25
Staging S3	10
Staging S4-S5	9
Cirrhosis S6	2
Genotype
1a	14
1b	75
2	54
3	5
4	2
Comorbidity
Cardiovascular diseases	13
Thyroid diseases	7
Crohn’s disease	1
GERD	2
Diabetes mellitus type 2	2
HBV co-infection	2

GERD: Gastroesophageal reflux disease; HBV: Hepatitis B virus.

Table 2 Liver fibrosis with paired assessment at baseline vs the end of follow-up

	Baseline		End of follow-up
Patients	METAVIR score	Corresponding value of LS (21) (kPa)	Mean value (range) of LS (kPa)	Mean follow-up (yr)	Patients with fibrosis regression
1	F0	< 6	5.9	10.6	0
18	F1	6.5 ± 1.1	5.4 (2.8-6.3)	9.48	13
6	F2	7.3 ± 1.4	6.2 (4.0-8.8)	6.02	4
0	F3	10.2 ± 1.9	-	-	-
1	F4	15 ± 4.1	6.8	8.3	1
1	Clinical cirrhosis	10.3	19.9	1	0

LS: Liver stiffness.